Axcelis Technologies (ACLS) EPS Estimated At $0.33, SEMLER SCIENTIFIC (SMLR) Sellers Decreased By 14.29% Their Shorts

July 17, 2017 - By Hazel Jackson

Analysts expect Axcelis Technologies Inc (NASDAQ:ACLS) to report $0.33 EPS on August, 3 after the close.They anticipate $0.23 EPS change or 230.00% from last quarter’s $0.1 EPS. ACLS’s profit would be $10.07M giving it 17.27 P/E if the $0.33 EPS is correct. After having $0.29 EPS previously, Axcelis Technologies Inc’s analysts see 13.79% EPS growth. About 392,726 shares traded. Axcelis Technologies Inc (NASDAQ:ACLS) has risen 132.61% since July 17, 2016 and is uptrending. It has outperformed by 115.91% the S&P500.

SEMLER SCIENTIFIC INCORPORATED (OTCMKTS:SMLR) had a decrease of 14.29% in short interest. SMLR’s SI was 2,400 shares in July as released by FINRA. Its down 14.29% from 2,800 shares previously. With 1,000 avg volume, 2 days are for SEMLER SCIENTIFIC INCORPORATED (OTCMKTS:SMLR)’s short sellers to cover SMLR’s short positions. It is 0.00% or $0 reaching $3 per share. It is down 0.00% since July 17, 2016 and is . It has underperformed by 16.70% the S&P500.

Axcelis Technologies, Inc. designs, makes and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. The company has market cap of $695.76 million. The Firm also provides aftermarket lifecycle services and products, including used tools, spare parts, equipment upgrades, maintenance services and customer training. It has a 38.65 P/E ratio. The Firm offers a complete line of high energy, high current and medium current implanters for all application requirements.

Among 4 analysts covering Axcelis Technologies (NASDAQ:ACLS), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. Axcelis Technologies had 6 analyst reports since August 8, 2015 according to SRatingsIntel. As per Tuesday, September 22, the company rating was downgraded by TheStreet. The rating was maintained by Benchmark with “Buy” on Thursday, November 5. The stock of Axcelis Technologies Inc (NASDAQ:ACLS) earned “Buy” rating by Needham on Wednesday, October 5. The company was maintained on Friday, June 16 by Needham. On Saturday, August 8 the stock rating was upgraded by TheStreet to “Hold”. On Friday, January 13 the stock rating was downgraded by Stifel Nicolaus to “Hold”.

Semler Scientific, Inc. develops, manufactures and markets services and products that assist healthcare insurers and physician groups in evaluating and treating chronic diseases. The company has market cap of $15.94 million. The Firm markets QuantaFlo and WellChec to its customers. It currently has negative earnings. QuantaFlo is an approximately four-minute in-office blood flow test.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: